A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor.
Clin Cancer Res
; 29(18): 3659-3667, 2023 09 15.
Article
in En
| MEDLINE
| ID: mdl-37363962
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunoconjugates
/
Gastrointestinal Stromal Tumors
/
Neoplasms
/
Antineoplastic Agents
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2023
Document type:
Article
Country of publication:
Estados Unidos